Evozyne
Aleina Lee is an experienced accounting professional currently serving as Controller at Evozyne since 2022, following a similar role at Acadis® from 2021 to 2022. Prior to that, Aleina held the position of Director of Accounting at PLNTF Holdings, LLC. from 2019 to 2021. Previous roles include Manager and Senior Accountant at Coates Group between 2016 and 2019, and Senior Accountant at Kaufman Hall from 2014 to 2016. Aleina began a career in accounting as a Staff Accountant at Cartridge World North America and the Korean Cultural Center of Chicago, where responsibilities included a Board Member role. Earlier experience encompasses various accounting positions at the American Library Association and as a Sales Coordinator at Samwha USA, Inc. Aleina holds a Bachelor of Science in Business Administration from Yonsei University, earned in 2003.
Evozyne
1 followers
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.